MedPath

SoVarGen Co., Ltd.

SoVarGen Co., Ltd. logo
🇰🇷South Korea
Ownership
Holding
Established
2018-01-01
Employees
11
Market Cap
-
Website
http://www.sovargen.com

Randomized Crossover of SVG101(Dispersible Tab. of Everolimus) and Afinitor 5mg in Healthy Adults

Phase 1
Completed
Conditions
Pharmacokinetics
Interventions
Drug: SVG101 (T)
First Posted Date
2022-08-05
Last Posted Date
2022-08-05
Lead Sponsor
SoVarGen Co., Ltd.
Target Recruit Count
26
Registration Number
NCT05490095
Locations
🇰🇷

Yonsei University Healthcare System, Severance Hospital, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath